4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 4
Accession 0000950170-24-107489
CIK 0001776111other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 7:15 PM ET
Size
10.8 KB
Accession
0000950170-24-107489
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2024-09-16+403,787→ 1,790,122 total - Conversion
Series B Preferred Stock
2024-09-16−16,666,666→ 0 total→ Common Stock (1,386,335 underlying) - Conversion
Common Stock
2024-09-16+1,386,335→ 1,386,335 total - Conversion
Series C Preferred Stock
2024-09-16−4,854,368→ 0 total→ Common Stock (403,787 underlying)
Footnotes (2)
- [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 12.0221-for-one basis. The Series B Preferred Stock had no expiration date.
- [F2]Immediately prior to the closing of the Issuer's initial public offering, each share of Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 12.0221-for-one basis. The Series C Preferred Stock had no expiration date.
Documents
Issuer
MBX Biosciences, Inc.
CIK 0001776111
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001903360
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 7:15 PM ET
- Size
- 10.8 KB